Varies by study
Selective Nerve Root Block
Total Trials
2
Max Phase
-
Type
MIXED
Molecule
-
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
1 source entries across 1 studies. This list may not include all unresolved or historical entries.
- Selective Nerve Root BlockRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Not Applicable
1
50%
Phase 4
1
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Terminated(1)
Detailed Status
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
not_yet_recruiting150%
terminated150%
Recent Activity
Clinical Trials (2)
Showing 2 of 2 trials
NCT07895589Not Applicable
Selective Nerve Root Block Versus Sham to Reduce Surgery for Lumbar Disc Herniation
NCT03801356Phase 4
Threshold Response of Lumbar Selective Nerve Root Block in Predicting Good Outcome Following Lumbar Foraminotomy
All 2 trials loaded
Drug Details
- Intervention Type
- Varies by study
- Total Trials
- 2